Hydration therapy is a therapy that delivers fluids directly into the bloodstream through a small IV inserted into the arm. The fluids may include electrolytes, vitamins, antioxidants, and even medication in the mixture. By allowing fluids to circulate quickly through the body, hydration therapy rapidly replenishes fluids in a way that drinking fluids can’t.
The Europe IV hydration therapy market is estimated to be valued at US$ 244.1 million in 2022 and is expected to exhibit a CAGR of 7.2% during the forecast period (2022-2030).
Figure 1.Europe IV Hydration Therapy Market Share (%) in Terms of Value, by Component Type, 2022
The increasing strategies adopted by the key players such as establishments of clinics offering IV therapies is expected to drive growth of the Europe IV hydration therapy market over the forecast period
The increasing establishments of clinics offering IV therapies to increase the geographical presence of the companies is expected to drive the market growth over the forecast period. For instance, in 2018, REVIV, a company that offers IV therapies and vitamin injections, launched clinics at New York, London, and Hong Kong, in order to expand the healthcare services in various regions at global level.
|Base Year:||2021||Market Size in 2022:||US$ 244.1 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||7.2%||2030 Value Projection:||US$ 427.0 Mn|
REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, Séchoir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc.
|Restraints & Challenges:||
Figure 2.Europe IV Hydration Therapy Market Share (%), by Activity, 2022
High burden of foodborne illness is expected to drive the market growth during the forecast period
The increasing burden of foodborne illness such as food poisoning, diarrhea, and others is expected to drive the growth of the Europe IV hydration therapy market over the forecast period. For instance, according to the data published by the World Health Organization (WHO) in June 2019, it was estimated that every minute, 44 people – more than 23 million per year fall sick from eating contaminated food, and an estimated 4700 per year lose their lives in Europe
Europe IV Hydration Therapy Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus or COVID-19 outbreak started in Wuhan, China in 2019 and spread across all the continents of the world, affecting various industries globally. The economies of countries all over the world, such as India, Italy, Bangladesh, Sri Lanka, the U.S., Morocco, and others, have been disrupted due to lockdowns implemented by governments to combat the spread of coronavirus since 2020.
However, COVID-19 pandemic positively impacted the Europe IV hydration therapy market, due to the use of IV therapies in COVID-19 patients. IV hydration therapy is a treatment that is used to boost the body's immunity by replenishing it with essential vitamins, antioxidants, and minerals to recover from various diseases such as migraines, flu, colds, or deficiencies in specific minerals or vitamins, which is expected to drive growth the market growth. Market players are indulged in developing new product which is expected to drive the Europe IV hydration therapy market over the forecast period. For instance, on November 11, 2021, Drip Hydration, a company in Europe that provides intravenous (IV) hydration, announced Covid IV therapy as a new IV treatment that was designed specifically to treat coronavirus. This virus is often misdiagnosed, which leads to more complications and even death. The IV therapy for COVID recovery aims to correct the health issues by providing high doses of antiviral medication through an IV line, while simultaneously addressing possible underlying infections. Thus, the COVID-19 pandemic had a positive impact on the Europe IV hydration therapy market
Europe IV Hydration Therapy Market: Restraint
The major factors that hinder growth of the Europe IV hydration therapy market include lack of accuracy of infusion pumps and high costs associated with infusion pumps. Pump failures can have high implications on patient’s safety, as these are used for delivering high-risk medications. Thus, the lack of accuracy in delivering the correct volume and dose of fluid can act as a restrain to the market growth.
Major players operating in the Europe IV hydration therapy market include REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, Séchoir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc.
IV therapy, also known as IV hydration therapy, is a treatment that boosts the body's immunity by replenishing it with important vitamins, antioxidants, and minerals. The technique, which is similar to drip hydration used in hospitals, helps ease symptoms of dehydration and other disorders by delivering nutrients directly into the bloodstream via drips. It is also believed that nutritional IV therapy can provide a variety of health benefits, including eliminating toxins from the body, increasing energy levels, and promoting better cardiovascular health, among others.
The increasing adoption of growth strategies by the key players in the market such as geographic expansion in order to enhance its market position at global level is expected to drive the market growth over the forecast period. For instance, in September 2021, VITANOVAS, a mobile IV infusion company, announced that the company is planning to develop into franchised clinics in Brussels, Belgium and Cancun, Mexico. The aim behind this expansion of VITANOVAS for IV therapy is to expand the business at global level.
Moreover, rising prevalence of obesity is expected to drive the market growth over the forecast period as IV hydration supports weight loss with fluids that body needs to thrive. For instance, according to the data published by Eurostat, the statistical office of the European Union, responsible for publishing high-quality Europe-wide statistics, in July 2021, more than half (53%) of adults in Europe were overweight (36% pre-obese and 17% obese) in the year 2019
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.